Skip to main content
. 2022 Aug 26;12:927781. doi: 10.3389/fonc.2022.927781

Table 4.

Treatment-related adverse events [N = 30, No. (%)].

Toxic effects Grade 1 Grade 2 Grade 3 Grade 4/5
Hematologic
 Leukopenia 7 (23.3%) 4 (13.3%) 0 0
 Neutropenia 5 (16.7%) 4 (13.3%) 0 0
 Anemia 9 (30.0%) 6 (6.7%) 0 0
 Thrombocytopenia 3 (10.0%) 0 0 0
 ALT increase 5 (16.7%) 1 (3.3%) 1 (3.3%) 0
 AST increase 3 (10.0%) 0 1 (3.3%)
Non-hematologic
 Vomiting 3 (10.0%) 0 0 0
 Diarrhea 6 (20.0%) 2 (6.7%) 0 0
 Hypothyroidism 0 1 (3.3%) 0 0
 Pneumonia 3 (10.0%) 0 0 0
 Dermatitis 1 (3.3%) 0 1 (3.3%) 0